Assessment of PFM Strength and Function After Radiotherapy Treatment in Women With Pelvic Cancers

Assessment of Pelvic Floor Muscles Strength and Function After Radiotherapy Treatment in Women With Pelvic Cancers

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06820801

Acronym

PFM

Enrollment

Registered

2025-02-11

Start date

2024-01-10

Completion date

2024-12-10

Last updated

2025-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Muscle Strength and Function

Keywords

pelvic floor muscles - radiotherapy - pelvic cancers

Brief summary

Assessment the effect of radiotherapy treatment on pelvic floor muscles in women with pelvic cancers

Detailed description

Evaluate the impact of radiotherapy treament on pelvic floor muscles strength and function in women with cervical and rectal cancers

Interventions

OTHERpelvic floor muscles strength and function

using pressure perineometer to evaluate pelvic floor muscles strength and using PFDI to evaluate pelvic floor muscles function

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

30 Years to 50 Years

Healthy volunteers

Inclusion criteria

* women between 30 -50 years old * diagnosed with cervix or rectal cancers * married * will be treated with preoperative radiotherapy for at least 5 weeks * had not any pelvic operations in the past

Exclusion criteria

* un married women * Age below 30 or above 50 years old * has another type of pelvic tumors * has any metastasis * had any pelvic surgeries * will be treated with short course radiotherapy

Design outcomes

Primary

Measure	Time frame	Description
PFM strength and function	3 months	Pelvic floor muscles strength and function

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026